Literature DB >> 19339236

Quality of ceftriaxone in Pakistan: reality and resonance.

Ali Obaid1.   

Abstract

The quality of pharmaceuticals is a global concern, counterfeit/ poor quality/ substandard medicines can cause harms in various ways: In a number of developing countries including Pakistan there is reportedly a high incidence of the availability of substandard drugs. The majority of these reports do not contain quantitative data to support these claims, nor do they describe the methodology employed for the quality assessment. Quality of drugs available in Pakistan are being questioned and topic of discussion in local news paper, TV channels in general public including journalist and physicians due to disparity of price among same generics, lack of knowledge for such science and unknown reasons. Since, quality of drugs can neither be assessed by naked eye or by every one therefore, randomly selected, 96 samples of different strength of injection ceftriaxone sodium and its generic, a widely used third generation cephalosporin in Pakistan since 1982 and 1994 till date respectively included in the said study to know the reality. 15.62% of ceftriaxone injection was found to be out of specification, however, not a single sample was found fake (spurious) out of 96 tested samples. Nevertheless, quality is a wide ranging concept covering all matters that individually or collectively influence the excellence of a product hence price and other related issues are also analyzed in the study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339236

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  6 in total

Review 1.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Assessment of the price-efficacy relationship for multiple brands of ceftriaxone sodium in Kabul: a cross-sectional study.

Authors:  H M Naimi; H Rasekh; M Haem Rahimi; H Yousofi
Journal:  BMC Res Notes       Date:  2016-02-12

3.  Identification of Multiple Low-Level Resistance Determinants and Coselection of Motility Impairment upon Sub-MIC Ceftriaxone Exposure in Escherichia coli.

Authors:  Carly Ching; Muhammad H Zaman
Journal:  mSphere       Date:  2021-11-17       Impact factor: 4.389

4.  Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries.

Authors:  Sachiko Ozawa; Hui-Han Chen; Yi-Fang Ashley Lee; Colleen R Higgins; Tatenda T Yemeke
Journal:  Am J Trop Med Hyg       Date:  2022-06-15       Impact factor: 3.707

5.  Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Authors:  Sachiko Ozawa; Daniel R Evans; Sophia Bessias; Deson G Haynie; Tatenda T Yemeke; Sarah K Laing; James E Herrington
Journal:  JAMA Netw Open       Date:  2018-08-03

Review 6.  Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.

Authors:  Huma Rasheed; Ludwig Hoellein; Khalid Saeed Bukhari; Ulrike Holzgrabe
Journal:  J Pharm Policy Pract       Date:  2019-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.